News & Media
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva enters opioid settlement agreement with US state Rhode Island
The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association
News & Media
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Jury holds drugmaker Teva liable in opioid crisis | WLUK
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
AMC, Teva, launch coalition for equity through digital health
Teva shed 37% of Israel workforce in two years - Globes
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
Teva Reports Third Quarter 2021 Financial Results
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva Pharmaceutical Industries Limited (TEVA) - Faruqi & Faruqi LLP
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
